STOCK TITAN

Verano Announces Conference Participation for April

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced upcoming participation in several significant cannabis industry conferences. Aaron Miles, Chief Investment Officer, and Julianna Paterra, Vice President of Investor Relations, will present at the SHARE Series Conference at the New York Stock Exchange on April 10, 2023. Miles will also join a panel at the Benzinga Cannabis Capital Conference on April 11, 2023. Additionally, CEO George Archos will take part in a fireside chat during the AdvisorShares “4/20 CannaBuzz” event on April 20, 2023. Verano continues to strengthen its presence across 14 U.S. states, emphasizing its commitment to improving communal wellness through regulated cannabis products.

Positive
  • Participation in three prominent cannabis conferences enhances brand visibility.
  • The presence at the New York Stock Exchange may strengthen investor relations.
Negative
  • None.

CHICAGO, April 03, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will participate in the following conferences:

SHARE Series Conference Inaugural Hybrid Event Live from the New York Stock Exchange
Aaron Miles, Chief Investment Officer, and Julianna Paterra, Vice President of Investor Relations, will give a presentation onsite at the NYSE and ring the closing bell alongside conference presenters.

DATE: April 10, 2023
TIME: 3:00 p.m. ET
LINK: https://www.openexchange.tv/sharetm-nyse-exclusive-event-april-10th

Benzinga Cannabis Capital Conference
Aaron Miles, Chief Investment Officer, will participate in a panel.
DATE: April 11, 2023
TIME: 11:20 a.m. ET

AdvisorShares 4/20 CannaBuzz Event
George Archos, Chief Executive Officer, will participate in a fireside chat.
DATE: April 20, 2023
TIME: 1:00 p.m. ET
LINK: Event will be streamed and available online via YouTube, LinkedIn, and Twitch.

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of high-quality, innovative cannabis products sold under its trusted portfolio of consumer brands, Verano, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 14 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MÜV, delivering a superior cannabis shopping experience in both medical and adult use markets. Learn more at www.verano.com.

Contacts:

Media
Verano
Steve Mazeika
Vice President, Communications
Steve.Mazeika@verano.com
312-348-4430

Investors
Verano
Julianna Paterra, CFA
Vice President, Investor Relations
investors@verano.com

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s Form 10-K filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###


FAQ

What are the dates for Verano's upcoming conferences in April 2023?

Verano will participate in three conferences: SHARE Series on April 10, Benzinga Cannabis Capital Conference on April 11, and AdvisorShares “4/20 CannaBuzz” on April 20.

Who will represent Verano Holdings at the SHARE Series Conference?

Aaron Miles, Chief Investment Officer, and Julianna Paterra, Vice President of Investor Relations, will represent Verano at the SHARE Series Conference.

What is the significance of Verano presenting at the New York Stock Exchange?

Presenting at the New York Stock Exchange increases Verano's visibility and may enhance investor confidence.

When will Verano's CEO participate in a fireside chat?

CEO George Archos will participate in a fireside chat during the AdvisorShares '4/20 CannaBuzz' event on April 20, 2023.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

454.84M
302.30M
14.26%
10.54%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago